The global medical disposables market size was exhibited at USD 435.8 billion in 2022 and is projected to hit around USD 2,076.96 billion by 2032, growing at a CAGR of 16.7% during the forecast period 2023 to 2032.
Key Pointers:
Medical Disposables Market Report Scope
Report Coverage | Details |
Market Size in 2023 | USD 509.45 Billion |
Market Size by 2032 | USD 2,076.96 Billion |
Growth Rate From 2023 to 2032 | CAGR of 16.9% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Segments Covered | Product, Raw material, End-use |
Companies Mentioned | Medline Industries, Inc.; Smith & Nephew PLC; Bayer AG; BD; 3M; Cardinal Health |
Regions Covered | North America; Europe; Asia Pacific; Latin America; MEA |
The growth of the market is attributable to the increasing number of surgical procedures, rising incidence of Hospital Acquired Infections (HAIs), growing prevalence of chronic diseases leading to longer hospital admission, and the impact of COVID-19 outbreaks across the globe.
The COVID-19 outbreak and increasing hospital admissions across the globe have significantly increased the demand for medical disposables. The WHO has appealed to industries and governments to increase the manufacturing of personal protective equipment, including hospital gowns, gloves, medical masks, face shields, aprons, respirators, and goggles, by 40.00% to meet the increasing global demand. It also reported that the increase in demand for these accessories has increased their prices to a major extent. For instance, the price of surgical masks has increased six-fold and the price of hospital gowns has increased two-fold. Furthermore, the WHO has shipped around half a million sets of personal protective equipment to around 47 countries. Therefore, the outbreak of COVID-19 has immensely impacted the market and is a highly effective driver for this market.
The outbreak of COVID-19 is anticipated to significantly impact the market for medical disposables. The pandemic caused by the virus SARS-CoV-2 has drastically increased the demand for medicines, medical disposable products, emergency supplies, and hospital equipment including gowns, antiseptics, and disinfectant products. COVID-19 is a zoonotic virus and bats were considered to be the key reservoir of the virus. In December 2019, the first patient was reported in China and since then, the disease has spread at a rapid pace. The first case was reported in Wuhan and has been identified that the infection was acquired from a zoonotic source. Post that incident human-to-human transmission of the virus largely took place in families within Wuhan.
Increasing number of surgeries globally is a key factor expected to drive the market over the forecast period. For instance, as per Mölnlycke Health Care AB, 70.00 million surgical procedures are performed every year in Europe. As such, medical disposable products such as hospital gowns, disposables eye gear, hand sanitizers, respiratory supplies, and sterilization supplies, which are being an essential requirement for surgical procedures, are expected to witness high demand over the forecast period. For instance, as per the report published by the Organization for Economic Co-operation and Development (OECD), around 390,352 surgeries were performed in Canada in 2017. Disposable products prevent the transmission of nosocomial infections to some extent owing to which surgeons consistently prefer to use disposable products over the reusable ones. Such factors are expected to boost market growth.
Increasing incidence of HAIs due to lack of sanitation and precaution is also one of the leading factors contributing to the market growth. For instance, as per the CDC, about one in 25 hospital patients contracts at least one HAI every year. Non-woven disposables such as hospital gowns provide general protection against contamination and can help to lower the risk of contracting HAIs. Furthermore, they can prevent bacterial and other microbial infections from entering a patient’s body. Thus, surgeons recommend patients to wear disposable gowns before medical procedures. These factors are anticipated to propel the market growth over the forecast period.
Some of the prominent players in the Medical disposables Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global medical disposables market.
By Product
By Raw Material
By End-use
By Region
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Medical Disposables Market, By Product
7.1. Medical Disposables Market, by Product Type, 2023-2032
7.1.1. Wound Management Products
7.1.1.1. Market Revenue and Forecast (2020-2032)
7.1.2. Drug Delivery Products
7.1.2.1. Market Revenue and Forecast (2020-2032)
7.1.3. Diagnostic and Laboratory Disposables
7.1.3.1. Market Revenue and Forecast (2020-2032)
7.1.4. Dialysis Disposables
7.1.4.1. Market Revenue and Forecast (2020-2032)
7.1.5. Incontinence Products
7.1.5.1. Market Revenue and Forecast (2020-2032)
7.1.6. Respiratory Supplies
7.1.6.1. Market Revenue and Forecast (2020-2032)
7.1.7. Sterilization Supplies
7.1.7.1. Market Revenue and Forecast (2020-2032)
7.1.8. Non-woven Disposables
7.1.8.1. Market Revenue and Forecast (2020-2032)
7.1.9. Disposable Masks
7.1.9.1. Market Revenue and Forecast (2020-2032)
7.1.10. Disposable Eye Gear
7.1.10.1. Market Revenue and Forecast (2020-2032)
7.1.11. Disposable Gloves
7.1.11.1. Market Revenue and Forecast (2020-2032)
7.1.12. Hand Sanitizers
7.1.12.1. Market Revenue and Forecast (2020-2032)
7.1.13. Others
7.1.13.1. Market Revenue and Forecast (2020-2032)
Chapter 8. Global Medical Disposables Market, By Application
8.1. Medical Disposables Market, by Application, 2023-2032
8.1.1. Hospitals
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Home Healthcare
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Outpatient/Primary Care Facilities
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Medical Disposables Market, By Raw Material
9.1. Medical Disposables Market, by Raw Material, 2023-2032
9.1.1. Plastic Resins
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Nonwoven Material
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Rubber
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Paper and Paperboard
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Metals
9.1.5.1. Market Revenue and Forecast (2020-2032)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Medical Disposables Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2020-2032)
10.1.2. Market Revenue and Forecast, by Application (2020-2032)
10.1.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.1.4.2. Market Revenue and Forecast, by Application (2020-2032)
10.1.4.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.1.5.2. Market Revenue and Forecast, by Application (2020-2032)
10.1.5.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.2. Market Revenue and Forecast, by Application (2020-2032)
10.2.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.4.2. Market Revenue and Forecast, by Application (2020-2032)
10.2.4.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
10.2.5.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
10.2.6.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.7.2. Market Revenue and Forecast, by Application (2020-2032)
10.2.7.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.2. Market Revenue and Forecast, by Application (2020-2032)
10.3.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.4.2. Market Revenue and Forecast, by Application (2020-2032)
10.3.4.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
10.3.5.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
10.3.6.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.7.2. Market Revenue and Forecast, by Application (2020-2032)
10.3.7.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.2. Market Revenue and Forecast, by Application (2020-2032)
10.4.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.4.2. Market Revenue and Forecast, by Application (2020-2032)
10.4.4.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
10.4.5.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
10.4.6.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.7.2. Market Revenue and Forecast, by Application (2020-2032)
10.4.7.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.5.2. Market Revenue and Forecast, by Application (2020-2032)
10.5.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.5.4.2. Market Revenue and Forecast, by Application (2020-2032)
10.5.4.3. Market Revenue and Forecast, by Raw Material (2020-2032)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.5.5.2. Market Revenue and Forecast, by Application (2020-2032)
10.5.5.3. Market Revenue and Forecast, by Raw Material (2020-2032)
Chapter 11. Company Profiles
11.1. Bayer AG
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. BD
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Smith & Nephew PLC
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Cardinal Health
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Medline Industries, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. 3M
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Covidien PLC.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Johnson & Johnson
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Becton
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Dickinson
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms